Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1495 of 5804
-
New pill shows promise for tough stomach cancer in early trial
Disease control OngoingThis is the first clinical trial of IDRX-42. The study is designed to evaluate the safety, tolerability, PK, and preliminary antitumor activity of IDRX-42 in adult participants with advanced (metastatic and/or surgically unresectable) GIST.
Phase: PHASE1 • Sponsor: IDRX, Inc., a wholly owned subsidiary of GSK, LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could this pill ease Meniere's hearing loss and dizziness?
Disease control CompletedThe study is a randomized, double-blind, placebo-controlled, multi-center clinical trial (RCT) with open-label extension study (OLE), of SPI-1005 in adult subjects with definite Meniere's disease with active symptoms within three months preceding study enrollment.
Phase: PHASE3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Massive global registry aims to unlock secrets of rett syndrome
Knowledge-focused Recruiting nowThe Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms …
Sponsor: International Rett Syndrome Foundation • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Experimental drug combo takes on tough cancers
Disease control CompletedThe primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in combination with nivolumab or nivolumab and ipilimumab to establish the maximum tolerated dose (MTD). The Recommended Phase 2 Dose (RP2D) that optimizes the pharmacokinetic…
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental drug shows promise for stiff heart disease
Disease control CompletedThis study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study will look at if this medicine can reduce the symptoms of a heart disease due to TTR amyloidosis, such as heart failure. Participants will either get …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Virtual reality offers new hope for facial paralysis sufferers
Symptom relief Recruiting nowPeripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Fasting during chemo: a new weapon against breast cancer?
Disease control OngoingThis randomized controlled trial investigates the effects of intermittent fasting and water-only fasting on gene expression, tumor markers, quality of life, and chemotherapy tolerance in breast cancer patients receiving chemotherapy. Breast cancer remains the most commonly diagno…
Phase: NA • Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for tough colorectal cancer: LYL273 trial opens
Disease control Recruiting nowThis is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with relapsed or refractory metastatic colorectal cancer.
Phase: PHASE1, PHASE2 • Sponsor: Lyell Immunopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Movie magic: new study tests films to keep kids still during cancer treatment
Symptom relief CompletedPROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect) is an interactive incentive-based movie system that integrates with a video surveillance gating module (VisionRT) as an alternative sedation solution for pediatric patients undergoing radiation treatment (R…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Urine test may spot hidden thyroid cancer, avoid unnecessary surgery
Diagnosis OngoingThyroid cancer is the most common endocrine malignancy in the world. Generally, thyroid cancer could be divided into well-differentiated and poorly-differentiated. Well-differentiated thyroid cancers usually have two different patterns, including papillary thyroid cancer and foll…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Gut bacteria transplant shows promise for recurring UTIs
Disease control Completedhis is a single-center, prospective, single-arm, interventional clinical study to evaluate the clinical efficacy, safety, and potential mechanisms of washed microbiota transplantation (WMT) in patients with recurrent urinary tract infections (rUTI). Recurrent UTI is defined as ≥2…
Phase: PHASE1, PHASE2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can oxygen during exercise supercharge lung rehab for ILD patients?
Symptom relief CompletedAlthough uncommon, interstitial lung diseases (ILDs), and particularly idiopathic pulmonary fibrosis (IPF), are progressive, irreversible, and ultimately fatal without treatment. Pharmacological therapies can slow the decline in forced vital capacity (FVC) and six-minute walk dis…
Phase: NA • Sponsor: Frédéric Hérengt • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could your diet boost your chance of having a baby?
Knowledge-focused Recruiting nowWorldwide infertility is highly prevalent and lifestyle factors, such as food intake, could have an essential role in the success of a fertility treatment. The literature is not consistent and adequate for recommendations to the increasing number of women and men of reproductive …
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Arthritis drug shows promise for rare, Life-Threatening skin conditions
Disease control CompletedThe goal of this study is to evaluate the effect of tofacitinib in patients with Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The primary outcome of the study is the time to complete re-epithelialization. The secondary outcomes are to determine mortality, …
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:13 UTC
-
Scientists create detailed brain maps to protect language during surgery
Knowledge-focused Recruiting nowThe purpose of this study is to compare organization of normal brain function as detected using Functional magnetic resonance imaging (fMRI) in normal subjects as opposed to patients with epilepsy or brain tumors, to ascribe precise anatomic labels (including Brodmann Areas) and …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingA Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of HBI-2438 and characterize its pharmacokinetic profile.
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Two drugs better than one for kids with high blood pressure in lungs?
Disease control CompletedThe investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosentan, will result in better World Health Organization (WHO) functional class at 1…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Ear stimulation helps babies avoid feeding tubes
Disease control CompletedFeeding is critical for pre-term infants and term infants with hypoxic ischemic brain injury, in order to be discharged home with their families and avoid a gastrostomy tube (G-tube) placement. The proposed study will employ a novel system that stimulates the vagus nerve through …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Tailored magnetic pulses aim to restore pleasure in depressed patients
Symptom relief CompletedThis program of research constitutes a three-arm, randomized, placebo-controlled trial testing noninvasive brain stimulation for the treatment of anhedonic depression. This trial is part of a larger, three-site study that will be conducted at UCSD, Stanford University, and Cornel…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
AI-Powered camera spots seizures without wires
Diagnosis CompletedNelli is a video-based non-EEG physiological seizure monitoring system. This study is a blinded comparison of Nelli's identified events to gold-standard video EEG review in at-rest pediatric subjects with suspected motor seizures.
Sponsor: Neuro Event Labs Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC